Russia

Doctors explain the principle of the Russian vaccine against coronavirus

Director of the National Research Center named after Gamaleya Alexander Gunzburg explained the principle of action of the developed vaccine against coronavirusTrials of the vaccine, developed by the Gamaleya National Center for Epidemiology and Microbiology, began in June at the same time at Sechenov University and the Burdenko Main Military Clinical Hospital


Director of the National Research Center named after Gamaleya Alexander Gunzburg explained the principle of action of the developed vaccine against coronavirus

Ministry of Defense of Russia / YouTube


Trials of the vaccine, developed by the Gamaleya National Center for Epidemiology and Microbiology, began in June at the same time at Sechenov University and the Burdenko Main Military Clinical Hospital

Ministry of Defense of Russia / YouTube

Director of the National Research Center named after Gamaleya Alexander Gunzburg explained the principle of the developed vaccine against coronavirus. According to him, the particles of coronavirus in the vaccine cannot harm the body, since they are inanimate and are created on the basis of adenovirus.

“Those particles are alive, those objects that can reproduce their own kind. These particles cannot multiply,” he said on the air of the channel “Russia 24”… Therefore, the vaccine cannot harm health, but it can cause discomfort, since when a foreign antigen is injected, the immune system begins to work in the vaccinated.

Gunzburg also noted that in some people in such circumstances, the temperature naturally rises: during clinical trials of the drug, the temperature in volunteers rose to 37, sometimes to 38 degrees, but this problem “removed with a paracetamol tablet”.

Trials of a vaccine developed by the Gamaleya National Center for Epidemiology and Microbiology began in June simultaneously at Sechenov University and Main Military Clinical Hospital named after Burdenko… According to the director of the Gamaleya Center Alexander Gintsburg, the first batches of the vaccine will arrive at medical institutions in mid-August, and mass production will begin in September.

The Ministry of Health of Russia reported that the documents required for registration of the vaccine of the Gamaleya Center are under examination. The issue of vaccine registration will be decided based on the results of the examination. “Interfax”… The state scientific center “Vector” of Rospotrebnadzor is also preparing for clinical trials of vaccines against coronavirus, where the registration of the first vaccine preparation may take place in the fall.

In addition to the Gamaleya and Vector Research Center for Epidemiology and Microbiology, the Biocard company and the St. Petersburg Research Institute (SRI) of vaccines and sera are also developing a vaccine against coronavirus. In addition, the FMBA of Russia and the Lomonosov Moscow State University are developing their own vaccine. At the same time, experts note that Russian developers of a vaccine against coronavirus are slightly behind in terms of their foreign colleagues, but at the same time they make extremely bold predictions about the time when the vaccine is ready for use. And the western press believes that drugs are being tested questionable methodsto “fulfill President Putin’s ambitious plan.”

.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button